Page last updated: 2024-09-03

n-(3-pyridyl)-3-phenylsuccinimide and Leukemia

n-(3-pyridyl)-3-phenylsuccinimide has been researched along with Leukemia in 1 studies

*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Blettner, M; Erdmann, F; Gianicolo, E; Merzenich, H; Russo, A; Wollschlaeger, D1

Other Studies

1 other study(ies) available for n-(3-pyridyl)-3-phenylsuccinimide and Leukemia

ArticleYear
Incidence of childhood leukemia before and after shut down of nuclear power plants in Germany in 2011: A population-based register study during 2004 to 2019.
    International journal of cancer, 2023, 03-01, Volume: 152, Issue:5

    Topics: Case-Control Studies; Child; Germany; Humans; Incidence; Leukemia; Nuclear Power Plants

2023